For example, selective inhibition of SUMO1 can induce G1 phase arrest, thereby inhibiting the formation and progression of glioblastoma (Bellail et al., 2014), and METTL3 can increase the metastatic potential of liver cancer when modified by SUMO1 (Xu et al., 2020). The gene discussed is SUMO1; the disease is liver cancer.